Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Major trial aims to boost lung cancer treatment power

NCT ID NCT04547504

Summary

This large, late-stage trial is testing if combining a standard chemotherapy with an immunotherapy drug (pembrolizumab) works better than using the immunotherapy drug alone. It's for people with a specific type of advanced non-small cell lung cancer who have not had prior treatment. The main goal is to see if the combination can help control the cancer for a longer time without it getting worse.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-SMALL-CELL LUNG CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • APHP - Hôpital Cochin

    Paris, 75014, France

  • CH Intercommunal de Créteil

    Créteil, 94010, France

  • CH La Roche Sur Yon - CHD Les Oudairies

    La Roche-sur-Yon, 85000, France

  • CH La Réunion - Site Félix Guyon

    Saint-Denis, 97400, France

  • CH MEAUX

    Meaux, 77108, France

  • CH d'Annecy-genevois

    Pringy, 74374, France

  • CH de Lorient - Hôpital du Scorff

    Lorient, 56100, France

  • CH du Pays d'Aix

    Aix-en-Provence, 13616, France

  • CHRU de Brest

    Brest, 29609, France

  • CHU AMIENS - Hôpital Sud

    Amiens, 80054, France

  • CHU Bordeaux - Hôpital du Haut Levêque

    Pessac, 33604, France

  • CHU La Réunion - Groupe Hospitalier Sud

    Saint-Pierre, 97410, France

  • CHU MARSEILLE_ Hopital Nord

    Marseille, 13915, France

  • CHU RENNES - Hôpital Pontchailloux

    Rennes, 35033, France

  • CHU ROUEN - Hôpital Charles Nicolle

    Rouen, 76031, France

  • Centre Hospitalier Métropole Savoie

    Chambéry, 73000, France

  • Centre Hospitalier de Cornouaille

    Quimper, 29000, France

  • Centre Léon Berard

    Lyon, 69008, France

  • Centre de lutte contre le cancer - Centre François Baclesse

    Caen, 14000, France

  • Ch Villefranche Sur Saone

    Villefranche-sur-Saône, 69655, France

  • Chu Angers

    Angers, 49033, France

  • Chu Dupuytren

    Limoges, 87042, France

  • Hôpital Européen Marseille

    Marseille, 13003, France

  • Hôpital d'Instruction des Armées Toulon - Saint Anne

    Toulon, 83041, France

  • Institut Gustave Roussy

    Villejuif, 94800, France

  • Institut Paoli-Calmette

    Marseille, 13000, France

  • Institut de Cancérologie Strasbourg Europe

    Strasbourg, 67200, France

  • SAINT-PRIEST EN JAREZ - Institut de Cancérologie de la Loire

    Saint-Priest-en-Jarez, 42271, France

  • Saint Aubin Les Elbeuf

    Saint-Aubin-lès-Elbeuf, 76503, France

Conditions

Explore the condition pages connected to this study.